Suchergebnisse - "Kitakaze, Masafumi"

PubPharm (896)

1

Effects of Dapagliflozin in Patients in Asia : A Post Hoc Subgroup Analysis From the DELIVER Trial

enthalten in: JACC. Asia | 2024

von Wang, X. | Lam, C. | Vaduganathan, M. | +18

2

Association Between B-Type Natriuretic Peptide Deficiency and Left Ventricular Concentric Hypertrophy in Subclinical Individuals

enthalten in: JACC. Asia | 2024

von Okamoto, C. | Tsukamoto, O. | Hasegawa, T. | +7

3

Metabolic syndrome is linked to the incidence of pancreatic cancer

enthalten in: EClinicalMedicine | 2024

von Miyashita, Y. | Hitsumoto, T. | Fukuda, H. | +8

4

Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes : insights from the randomized PROTECT trial

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2024

von Saito, Y. | Tanaka, A. | Imai, T. | +108

CommentIn: Hypertens Res. 2024 Jan 5;:. - PMID 38182906

5

Antacid Therapy in Coronary Artery Disease and Heart Failure : Proton Pump Inhibitors vs. H2 Receptor Blockers

enthalten in: Cardiovascular drugs and therapy | 2024

von Khawaja, M. | Thakker, J. | Kherallah, R. | +4

6

Author Correction : Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

enthalten in: Nature medicine | 2023

von Vardeny, O. | Fang, J. | Desai, A. | +21

ErratumFor: Nat Med. 2022 Dec;28(12):2504-2511. - PMID 36522606

7

Who Should Be the Corresponding Author, What Are Their Responsibilities, and What Email Address Should They Provide?

enthalten in: Cardiovascular drugs and therapy | 2023

von Birnbaum, Y. | Kitakaze, M. | Grieve, D. | +1

8

DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study) : a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial

enthalten in: EClinicalMedicine | 2023

von Yoshihara, F. | Imazu, M. | Sakuma, I. | +129

9

Trimetazidine to Reduce Myocardial Fibrosis-Competing Interests with SGLT2 Inhibitors?

enthalten in: Cardiovascular drugs and therapy | 2023

von Moran, T. | Kitakaze, M. | Birnbaum, Y.

10

Trimetazidine to Reduce Myocardial Fibrosis—Competing Interests with SGLT2 Inhibitors?

enthalten in: Cardiovascular drugs and therapy | 2023

von Moran, T. | Kitakaze, M. | Birnbaum, Y.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[90]